{"count": 100, "results": [{"_id": "32845585", "pmid": 32845585, "title": "Oral Metformin for Treating Dermatological Diseases: A Systematic Review.", "journal": "J Drugs Dermatol", "authors": ["Sung CT", "Chao T", "Lee A", "Foulad DP", "Choi F", "Juhasz M", "Dobry A", "Mesinkovska NA"], "date": "2020-08-01T00:00:00Z", "doi": "10.36849/JDD.2020.4874", "meta_date_publication": "2020 Aug 1", "meta_volume": "19", "meta_issue": "8", "meta_pages": "713-720", "score": 50267.71, "text_hl": "Application of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian disease@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@) related @DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@acne@@@, @DISEASE_Acanthosis_Nigricans @DISEASE_MESH:D000052 @@@acanthosis nigricans@@@, and @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ yielded mixed clinical results. ", "citations": {"NLM": "Sung CT, Chao T, Lee A, Foulad DP, Choi F, Juhasz M, Dobry A, Mesinkovska NA. Oral Metformin for Treating Dermatological Diseases: A Systematic Review. J Drugs Dermatol. 2020 Aug 1;19(8):713-720. PMID: 32845585", "BibTeX": "@article{32845585, title={Oral Metformin for Treating Dermatological Diseases: A Systematic Review.}, author={Sung CT and Chao T and Lee A and Foulad DP and Choi F and Juhasz M and Dobry A and Mesinkovska NA}, journal={J Drugs Dermatol}, volume={19}, number={8}, pages={713-720}}"}}, {"_id": "35815185", "pmid": 35815185, "title": "Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?", "journal": "Biomed Rep", "authors": ["Hamadneh J", "Amarin Z", "Alchalabi H", "Al-Bayyari N", "Hamadneh S"], "date": "2022-06-21T00:00:00Z", "doi": "10.3892/br.2022.1553", "meta_date_publication": "2022 Aug", "meta_volume": "17", "meta_issue": "2", "meta_pages": "70", "score": 50266.47, "text_hl": "It was concluded that polymorphisms in the @GENE_STK11 @GENE_6794 @@@STK11@@@ gene in either Intron 1 or Intron 6 were not predictive of the response to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy at a dose of 850 mg twice daily, but may have some effect on @DISEASE_Alopecia @DISEASE_MESH:D000505 @@@alopecia@@@ and @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@.", "citations": {"NLM": "Hamadneh J, Amarin Z, Alchalabi H, Al-Bayyari N, Hamadneh S. Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome? Biomed Rep. 2022 Aug;17(2):70. PMID: 35815185", "BibTeX": "@article{35815185, title={Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?}, author={Hamadneh J and Amarin Z and Alchalabi H and Al-Bayyari N and Hamadneh S}, journal={Biomed Rep}, volume={17}, number={2}, pages={70}}"}}, {"_id": "32794179", "pmid": 32794179, "title": "Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.", "journal": "Cochrane Database Syst Rev", "authors": ["Fraison E", "Kostova E", "Moran LJ", "Bilal S", "Ee CC", "Venetis C", "Costello MF"], "date": "2020-08-13T00:00:00Z", "doi": "10.1002/14651858.CD005552.pub3", "meta_date_publication": "2020 Aug 13", "meta_volume": "8", "meta_issue": "8", "meta_pages": "CD005552", "score": 50265.586, "text_hl": "Either @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone or the OCP alone may be less effective in improving @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combined with the OCP. ", "citations": {"NLM": "Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, Costello MF. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020 Aug 13;8(8):CD005552. PMID: 32794179", "BibTeX": "@article{32794179, title={Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.}, author={Fraison E and Kostova E and Moran LJ and Bilal S and Ee CC and Venetis C and Costello MF}, journal={Cochrane Database Syst Rev}, volume={8}, number={8}, pages={CD005552}}"}}, {"_id": "33683076", "pmid": 33683076, "title": "Adding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients.", "journal": "J Drugs Dermatol", "authors": ["Dorgham N", "Sharobim A", "Haggag H", "El-Kalioby M", "Dorgham D"], "date": "2021-03-01T00:00:00Z", "doi": "10.36849/JDD.5652", "meta_date_publication": "2021 Mar 1", "meta_volume": "20", "meta_issue": "3", "meta_pages": "302-306", "score": 50264.61, "text_hl": "@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@Polycystic ovary syndrome@@@ is a major cause of @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@. AIM: Assessing the impact of adding combined oral contraceptives (COCs) or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to laser hair removal on the quality of life of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@) @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@. ", "citations": {"NLM": "Dorgham N, Sharobim A, Haggag H, El-Kalioby M, Dorgham D. Adding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients. J Drugs Dermatol. 2021 Mar 1;20(3):302-306. PMID: 33683076", "BibTeX": "@article{33683076, title={Adding Combined Oral Contraceptives or Metformin to Laser Treatment in Polycystic Ovarian Syndrome Hirsute Patients.}, author={Dorgham N and Sharobim A and Haggag H and El-Kalioby M and Dorgham D}, journal={J Drugs Dermatol}, volume={20}, number={3}, pages={302-306}}"}}, {"_id": "32983332", "pmid": 32983332, "title": "Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study.", "journal": "J Clin Aesthet Dermatol", "authors": ["Fonseka S", "Wijeyaratne CN", "Gawarammana IB", "Kalupahana NS", "Rosairo S", "Ratnatunga N", "Kumarasiri R"], "date": "2020-07-01T00:00:00Z", "meta_date_publication": "2020 Jul", "meta_volume": "13", "meta_issue": "7", "meta_pages": "18-23", "score": 50262.727, "text_hl": "CONCLUSION: EE/CPA and EE/@CHEMICAL_Diethylstilbestrol @CHEMICAL_MESH:D004054 @@@DES@@@ were equally effective in improving @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, with no added benefit from low-dose @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Fonseka S, Wijeyaratne CN, Gawarammana IB, Kalupahana NS, Rosairo S, Ratnatunga N, Kumarasiri R. Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study. J Clin Aesthet Dermatol. 2020 Jul;13(7):18-23. PMID: 32983332", "BibTeX": "@article{32983332, title={Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study.}, author={Fonseka S and Wijeyaratne CN and Gawarammana IB and Kalupahana NS and Rosairo S and Ratnatunga N and Kumarasiri R}, journal={J Clin Aesthet Dermatol}, volume={13}, number={7}, pages={18-23}}"}}, {"_id": "39331347", "pmid": 39331347, "title": "Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.", "journal": "Endocrine", "authors": ["Kelly FA", "de Oliveira Macena Lôbo A", "Cardoso JHCO", "de Moraes FCA"], "date": "2024-09-27T00:00:00Z", "doi": "10.1007/s12020-024-04052-3", "meta_date_publication": "2024 Sep 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50257.473, "text_hl": "CONCLUSION: In this meta-analysis of RCTs, combination therapy was associated with cycle regularization and reduction in @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ and LH/FSH ratio compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy. ", "citations": {"NLM": "Kelly FA, de Oliveira Macena Lôbo A, Cardoso JHCO, de Moraes FCA. Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine. 2024 Sep 27;():. PMID: 39331347", "BibTeX": "@article{39331347, title={Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.}, author={Kelly FA and de Oliveira Macena Lôbo A and Cardoso JHCO and de Moraes FCA}, journal={Endocrine}}"}}, {"_id": "36299963", "pmid": 36299963, "pmcid": "PMC9588252", "title": "A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills", "journal": "Cureus", "authors": ["Fattah A", "Al-Kader DA", "Jones Amaowei EE", "Amini H", "Hewadmal H", "Rasuli SF", "Ikedum IV", "Farooq J", "Bashar M", "Qadar LT"], "date": "2022-09-23T00:00:00Z", "doi": "10.7759/cureus.29487", "meta_date_publication": "2022 Sep", "meta_volume": "14", "meta_issue": "9", "meta_pages": "e29487", "score": 50256.57, "text_hl": "In @SPECIES_9606 @@@human@@@ studies, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has been shown to reduce @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@, stimulate ovulation, and restore a regular menstrual cycle. ", "citations": {"NLM": "Fattah A, Al-Kader DA, Jones Amaowei EE, Amini H, Hewadmal H, Rasuli SF, Ikedum IV, Farooq J, Bashar M, Qadar LT. A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills Cureus. 2022 Sep;14(9):e29487. PMID: 36299963", "BibTeX": "@article{36299963, title={A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills}, author={Fattah A and Al-Kader DA and Jones Amaowei EE and Amini H and Hewadmal H and Rasuli SF and Ikedum IV and Farooq J and Bashar M and Qadar LT}, journal={Cureus}, volume={14}, number={9}, pages={e29487}}"}}, {"_id": "33324861", "pmid": 33324861, "pmcid": "PMC7724745", "title": "Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents", "journal": "J Endocr Soc", "authors": ["Al Khalifah RA", "Florez ID", "Zoratti MJ", "Dennis B", "Thabane L", "Bassilious E"], "date": "2020-10-17T00:00:00Z", "doi": "10.1210/jendso/bvaa155", "meta_date_publication": "2021 Jan 1", "meta_volume": "5", "meta_issue": "1", "meta_pages": "bvaa155", "score": 50255.35, "text_hl": "Moderate-quality evidence showed @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ scores were reduced by multiple interventions that included single and combination medications namely; lifestyle intervention, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, OCP, @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-OCP, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Flutamide @CHEMICAL_MESH:D005485 @@@flutamide@@@ against placebo. ", "citations": {"NLM": "Al Khalifah RA, Florez ID, Zoratti MJ, Dennis B, Thabane L, Bassilious E. Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents J Endocr Soc. 2021 Jan 1;5(1):bvaa155. PMID: 33324861", "BibTeX": "@article{33324861, title={Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents}, author={Al Khalifah RA and Florez ID and Zoratti MJ and Dennis B and Thabane L and Bassilious E}, journal={J Endocr Soc}, volume={5}, number={1}, pages={bvaa155}}"}}, {"_id": "37583655", "pmid": 37583655, "pmcid": "PMC10424142", "title": "Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials", "journal": "EClinicalMedicine", "authors": ["Alesi S", "Forslund M", "Melin J", "Romualdi D", "Peña A", "Tay CT", "Witchel SF", "Teede H", "Mousa A"], "date": "2023-08-09T00:00:00Z", "doi": "10.1016/j.eclinm.2023.102162", "meta_date_publication": "2023 Sep", "meta_volume": "63", "meta_issue": "", "meta_pages": "102162", "score": 50255.043, "text_hl": "Combination treatment with anti-androgens + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ + lifestyle resulted in lower @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@ compared with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ + lifestyle (-0.29 nmol/l [-0.52, -0.06], p = 0.01; I2 = 61%), but there were no differences in @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ when anti-androgens + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ + lifestyle were compared with either anti-androgens + lifestyle or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ + lifestyle. ", "citations": {"NLM": "Alesi S, Forslund M, Melin J, Romualdi D, Peña A, Tay CT, Witchel SF, Teede H, Mousa A. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials EClinicalMedicine. 2023 Sep;63():102162. PMID: 37583655", "BibTeX": "@article{37583655, title={Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials}, author={Alesi S and Forslund M and Melin J and Romualdi D and Peña A and Tay CT and Witchel SF and Teede H and Mousa A}, journal={EClinicalMedicine}, volume={63}, pages={102162}}"}}, {"_id": "40781685", "pmid": 40781685, "title": "Evaluation of therapeutic effects of Crocin in patients with polycystic ovary syndrome: A randomized Double-Blind clinical trial.", "journal": "J Pharm Health Care Sci", "authors": ["Saghafi F", "Javaheri A", "Mohammadi F", "Hatamizadeh N", "Khanizadeh F", "Safakish M", "Sahebnasagh A"], "date": "2025-08-08T00:00:00Z", "doi": "10.1186/s40780-025-00432-7", "meta_date_publication": "2025 Aug 8", "meta_volume": "11", "meta_issue": "1", "meta_pages": "69", "score": 50251.23, "text_hl": "Fifty @SPECIES_9606 @@@patients@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ and @<m>DISEASE_Hirsutism</m> @DISEASE_MESH:D006628 @@@hirsutism@@@ were included from Baqaipour Obstetrics and Gynecology Clinic in Yazd and randomly assigned into the two study arms of control group [@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and placebo (n = 25)] or intervention group [@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_crocin @CHEMICAL_MESH:C029036 @@@crocin@@@ (n = 25)]. ", "citations": {"NLM": "Saghafi F, Javaheri A, Mohammadi F, Hatamizadeh N, Khanizadeh F, Safakish M, Sahebnasagh A. Evaluation of therapeutic effects of Crocin in patients with polycystic ovary syndrome: A randomized Double-Blind clinical trial. J Pharm Health Care Sci. 2025 Aug 8;11(1):69. PMID: 40781685", "BibTeX": "@article{40781685, title={Evaluation of therapeutic effects of Crocin in patients with polycystic ovary syndrome: A randomized Double-Blind clinical trial.}, author={Saghafi F and Javaheri A and Mohammadi F and Hatamizadeh N and Khanizadeh F and Safakish M and Sahebnasagh A}, journal={J Pharm Health Care Sci}, volume={11}, number={1}, pages={69}}"}}]}